We are pleased to announce the acquisition of a next-generation investigational oncolytic virus (ICVB-1042) and multiple strategic research collaborations. Join our management team during a live conference call and webcast today at 12:00 PM ET to hear more about our long-term growth strategy. Join the Webcast: https://lnkd.in/gV7K4ekS
Very exciting Jim! Congrats.